{
  "symbol": "ABT",
  "name": "Abbott Laboratories",
  "sector": "Health Care",
  "industry": "Health Care Equipment",
  "date_added": "1957-03-04",
  "headquarters": "North Chicago, Illinois",
  "founded": "1888",
  "market_cap": 228980.342784,
  "pe_ratio": 17.114435,
  "forward_pe": 25.505816,
  "eps": 7.69,
  "revenue": 42344.001536,
  "profit_margin": 0.31886,
  "debt_to_equity": 27.087,
  "return_on_equity": 0.30649,
  "dividend_yield": 1.74,
  "current_price": 131.61000061035156,
  "year_high": 140.57881270421368,
  "year_low": 98.26899665076247,
  "price_change_1d": -1.3122375464837566,
  "price_change_1w": -3.41258922937289,
  "price_change_1m": -1.7395862241185014,
  "description": "Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, M\u00e9ni\u00e8re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate",
  "website": "https://www.abbott.com",
  "employees": 114000,
  "exchange": "NYQ",
  "currency": "USD",
  "analyst_target_price": 141.31693,
  "recommendation": 1.96552,
  "number_of_analysts": 26,
  "earnings_history": [],
  "analyst_data": {
    "target_high": 159.0,
    "target_low": 120.12,
    "target_mean": 141.31693,
    "target_median": 143.06
  },
  "last_updated": "2025-07-09T11:15:58.112878",
  "data_quality": {
    "has_financial_data": true,
    "has_earnings_data": false,
    "has_analyst_data": true,
    "completeness_score": 0.6666666666666666
  }
}